Liraglutide
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Novo Nordisk · Phase 3 · Completed · Enrollment 153
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- Metformin XR plus liraglutide: week 84 -7.2%
- Metformin XR plus placebo: week 84 -3.1%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.